At Biogen, our mission is clear: we are pioneers in neuroscience. One of the world’s first global biotechnology companies, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen has a portfolio of medicines to treat certain types of multiple sclerosis, has introduced an approved treatment for spinal muscular atrophy, developed five treatments for multiple sclerosis, and is focused on advancing neuroscience research programs for various diseases, including Alzheimer’s disease.
To learn more about Biogen please visit https://www.biogen.com/en_us/html.
For Biogen Medical Information, please contact medinfo@biogen.com.
For Investor Relations, please contact IR@biogen.com.
